TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav® Infusion System Growth Initiatives
TriSalus Reports Q4 and Full Year 2023 Financial Results and Business Update
TriSalus Presentations at the Society of Interventional Radiology Meeting
TriSalus Life Sciences Announces Oral Presentations at the Upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting
TriSalus Life Sciences Receives Approval from the World Health Organization
TriSalus Life Announces Real-World Data Demonstrating the Ability of TriNav
TriSalus Life Announces CMS Reimbursement for the TriNav® Infusion System
TriSalus Reports Third Quarter 2023 Financial Results
TriSalus Life to Host Third Quarter 2023 Financial Results Conference Call
Late-Breaking Phase 1 Liver Metastasis Data from TriSalus Presented at SITC 2023 Supports Development of Innovative Immuno-oncology Approach for Liver and Pancreas Indications